Erlotinib hydrochloride is a small molecule anticancer agent classified as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, commonly used to treat patients with non-small cell lung… Read more
Erlotinib hydrochloride is a small molecule anticancer agent classified as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, commonly used to treat patients with non-small cell lung cancer and pancreatic cancer. To support rigorous quality control and pharmaceutical research, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, relevant metabolites, and pharmacopeial and non-pharmacopeial impurities. Laboratories utilize these high-quality materials for impurity profiling, method development, and validation to ensure regulatory compliance during stability testing. Additionally, stable isotope-labelled standards are available for use as internal standards in quantitative analytical techniques, such as mass spectrometry, helping to enhance the accuracy and precision of drug analysis. By maintaining access to these standardized compounds, researchers can effectively monitor potential process-related impurities and degradation products throughout the lifecycle of the drug.